ELEVAI Labs Inks Licensing Deal With Yuva Biosciences to Develop New Topical Skincare Formulations and Aesthetics Products (VIDEO)

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement with Yuva Biosciences to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx™ (Precision Regenerative Exosome Technology™) to potentially develop topical skincare formulations that combine mitochondrial biology with Elevai’s human umbilical mesenchymal stem cell-derived exosomes.

Commenting on the announcement, ELEVAI Labs CEO Jordan R. Plews Ph.D., stated:

“We are excited to partner with Yuva Biosciences in order to begin research and development of products that may incorporate the power of mitochondrial technology to further advance the potential of Elevai exosomes to address cosmetic skin and hair concerns associated with signs of aging.”

Source: Aging Reversed YouTube

Also Read: ELEVAI Labs Closes $6 Million NASDAQ IPO

ELEVAI currently markets its proprietary ELEVAI E-Series™ which are peri-procedure topical exosome skincare products. Yuva Biosciences utilizes mitochondrial science to address signs of aging of hair, scalp, and skin. Yuva Biosciences has built a platform with a leading-edge AI model to rapidly screen huge numbers of natural compounds for their effectiveness in improving mitochondrial health.

Keshav K. Singh, Ph.D., Scientific Founder of Yuva Biosciences also commented on the new licensing deal, adding:

“YuvaBio, in partnership with Elevai, is researching topical cosmetic applications that may limit the appearance of human aging and we believe this research and development partnership has the potential to commercialize new cosmetics not found elsewhere.”

Source: ELEVAI Skincare YouTube

Click Here to Learn How to Buy ELEVAI Skincare Products

Shares of ELEVAI Labs (NASDAQ: ELAB) last traded at $3.56 per share. YTD, ELAB stock is up +4.26%.

Learn more about ELEVAI Labs: Website | Investor Deck | ELAB Chart

Follow ELEVAI on Social Media: Instagram | LinkedIn | Facebook | Twitter | YouTube

Join the Discussion in the Wealthy VC Investor Group

Have a Stock Tip or New  Story Suggestion? Email us at Invest@WealthyVC.com

Elevai Labs Inc. is a paid client of Wealthy VC.

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.

View Full Disclaimer Here